EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Cuprina Holdings (Cayman) Limited Class A (CUPR) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Cuprina Holdings (Cayman) Limited Class A $0.57, price $1.90, upside -70.0%, quality 35 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · ISIN KYG2592E1109

CH Cuprina Holdings (Cayman) Limited Class A logo Thin data Sep 24, 2026

Cuprina Holdings (Cayman) Limited Class A

CUPR · US

Weakest SetupStrongly overvalued and low quality.

!Fair value $0.5700 · Strongly overvalued (−70%)
!Quality 35/100
!Weak Growth (revenue 3y −4.1 %/yr)
!Low debt · negative free cash flow
!Mixed vs. peers (3/6)
!Narrow moat 38/100
!Evidence only low, so the estimate is less certain
Watch Cuprina Holdings (Cayman) Limited Class A Ordinary Shares for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$75.20 $1.60 Fair Value $0.5700 Apr 2025 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

17‑month range $1.60 – $75.20 · fair‑value band $0.3700 – $0.7100 · the $1.90 price screens above the $0.5700 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Cuprina Holdings (Cayman) Limited Class A Ordinary Shares in your weekly email

Every Wednesday you see whether Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.

Show more

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Stock analysis

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) currently trades at $1.90, while our model-based Fair Value estimate is $0.5700, implying the stock looks roughly 233.3% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.

Scenario range: $0.3700 (bear) to $0.7100 (bull), the price of $1.90 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares reported revenue of 49.9K SGD in FY2025 versus 58.5K SGD in FY2021, a compound −3.9%/yr. Reported net income was −4.7M SGD in FY2025.

Key figures

Market cap $8.6M · EPS (TTM) $−1.44 · Return on equity −1,569% · Return on assets (EBIT) −71.0% · Operating margin −10,568% · Revenue (TTM) 49.9K SGD · Revenue growth (YoY) +267% · Free cash flow −9.2M SGD.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (low confidence).

What moves the price

The share trades about 79% below its 52-week high and 19% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −13% fair-value upside, at −70%, CUPR screens richer than that median.

Fair Value models

Bear $0.3700 Fair Value $0.5700 Bull $0.7100
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $0.4700 $0.6300 $0.9400 54
All 1 models by family
Asset-Based
NCAV (Graham) $0.4700 $0.6300 $0.9400 54

Open the full fair value analysis →

Notify me when CUPR reaches fair value

Put CUPR on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 35/100

Of which business quality 37 · Market factors (momentum, volatility) 1

Profitability 0
Margins and returns on capital today
Quality Growth 53
Are margins and returns improving?
Cashflow 32
Earnings quality: real cash, not paper profit
Fin. Strength 72
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 1
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 60
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+3.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−944.8% (2021) → −9,154.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

CUPR screens 233% overvalued. Compare with Intuitive Surgical, Inc →

Compare Cuprina Holdings (Cayman) Limited Class A Ordinary Shares with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 204 stocks

Beats the industry median on 3/6 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 37 · Bottom 25%
Fair Value upside −70% · Bottom 25%
Profitability
Return on assets −59% · Bottom 25%
Growth and dividend
Revenue growth 267% · Top 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 1.70× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 14
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)0 · sector 25
HEALTH (low debt)99 · sector 96
DIVIDEND (yield)0 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $399.52 $348.72 −13%
EssilorLuxottica Société anonyme EL €144.70 €159.17 +10%
Medline Inc MDLN $34.30 $30.15 −12%
Becton, Dickinson and Company BDX $182.52 $103.53 −43%
Alcon Inc ALC $65.39 $39.78 −39%
ResMed Inc RMD A$31.70 A$34.87 +10%
West Pharmaceutical Services, Inc WST $375.87 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €215.80 €54.82 −75%
Straumann Holding STMN CHF 96.38 CHF 45.50 −53%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares · Fair Value
$0.5700 −233%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Fair Value". https://www.fairvalue-calculator.com/stock/CUPR

Frequently asked questions

Is Cuprina Holdings (Cayman) Limited Class A (CUPR) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.5700 versus a price of $1.90, about −70% upside (overvalued).
What is the fair value of CUPR?
Our model-based fair value for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is $0.5700 (as of Sep 24, 2026), built from audited fundamentals. The current price: $1.90.
What is the quality score of CUPR?
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Our model-based price target is the fair value of $0.5700 (as of Sep 24, 2026) from 1 valuation models. Cautious scenario $0.3700, optimistic scenario $0.7100. It is a calculation from audited fundamentals, not an analyst target.
What is the Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock forecast for 2026?
Our models put fair value at $0.5700, about −70% upside versus a price of $1.90 (overvalued). Cautious scenario $0.3700, optimistic scenario $0.7100. The calculation is refreshed regularly with new filings.
What is the revenue of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares reported trailing-twelve-month revenue of about 49.9K SGD (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cuprina Holdings (Cayman) Limited Class A Ordinary Shares it is $0.5700 per share (as of Sep 24, 2026), against a price of $1.90. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock overvalued or undervalued in 2026?
As of Sep 24, 2026, CUPR trades above its calculated fair value: price $1.90, fair value $0.5700, a gap of about −70% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CUPR?
No. The price is what the market pays today ($1.90); the fair value is what the company's own numbers justify ($0.5700). For Cuprina Holdings (Cayman) Limited Class A Ordinary Shares the two are $1.33 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares worth?
The market values Cuprina Holdings (Cayman) Limited Class A Ordinary Shares at about $8.6M (market capitalisation, as of Sep 24, 2026). Per share that is $1.90; our models calculate a fair value of $0.5700 per share.
What do the bullish and bearish scenarios say about CUPR?
Our models span a range for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares: cautious scenario $0.3700, base $0.5700, optimistic $0.7100 per share (as of Sep 24, 2026, price $1.90). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Balance-sheet figures for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (as of Sep 24, 2026): debt of 0.03 per unit of equity. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is CUPR from its 52-week high?
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares trades at $1.90, about 79% below its 52-week high of $8.96 and 19% above the low of $1.60 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of $0.5700 is for.
Which stocks are comparable to Cuprina Holdings (Cayman) Limited Class A Ordinary Shares?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock attractive at the current price?
The data as of Sep 24, 2026: price $1.90, calculated fair value $0.5700 (−70%), Quality Score 35/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CUPR calculated?
We run Cuprina Holdings (Cayman) Limited Class A Ordinary Shares through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.5700, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The closing price on Sep 24, 2026 was $1.90. Our model-based fair value is $0.5700, about −70% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cuprina Holdings (Cayman) Limited Class A Ordinary Shares right now?
The price sits above even our optimistic bull case ($0.7100). The favourable scenario is already priced in. Weak quality (35/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.3700 to $0.7100) leaves room in how you read the outcome.

Key figures of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

How large is the market capitalisation of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The market capitalisation of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is $8.6M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Earnings per share at Cuprina Holdings (Cayman) Limited Class A Ordinary Shares are $−1.44. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The return on equity (ROE) of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is −1,569% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
On an EBIT basis the return on assets of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is −71.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The operating margin of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is −10,568% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Revenue at Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is growing +267% versus a year earlier (3y avg −4.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Cuprina Holdings (Cayman) Limited Class A (CUPR) generate?
The free cash flow of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is −9.2M SGD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Cuprina Holdings (Cayman) Limited Class A (CUPR) hold?
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares holds more cash than debt, 2.6M SGD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Cuprina Holdings (Cayman) Limited Class A Ordinary Shares in the live analysis

One click puts Cuprina Holdings (Cayman) Limited Class A Ordinary Shares on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.